NO852519L - Substituerte 3,4-diamino-1,2,5-tiadiazoler med hestamin h2-reseptor antagonistisk virkning - Google Patents

Substituerte 3,4-diamino-1,2,5-tiadiazoler med hestamin h2-reseptor antagonistisk virkning

Info

Publication number
NO852519L
NO852519L NO852519A NO852519A NO852519L NO 852519 L NO852519 L NO 852519L NO 852519 A NO852519 A NO 852519A NO 852519 A NO852519 A NO 852519A NO 852519 L NO852519 L NO 852519L
Authority
NO
Norway
Prior art keywords
hestamine
thiadiazoles
diamino
substituted
antagonistic effect
Prior art date
Application number
NO852519A
Other languages
English (en)
Other versions
NO161856C (no
NO161856B (no
Inventor
Aldo A Algieri
Ronnie R Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO852519L publication Critical patent/NO852519L/no
Priority to NO872504A priority Critical patent/NO164711C/no
Publication of NO161856B publication Critical patent/NO161856B/no
Publication of NO161856C publication Critical patent/NO161856C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO852519A 1984-06-22 1985-06-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,4-diamino-1,2,5-tiadiazol-derivater. NO161856C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO872504A NO164711C (no) 1984-06-22 1987-06-16 Etan-diimidamid-derivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (3)

Publication Number Publication Date
NO852519L true NO852519L (no) 1985-12-23
NO161856B NO161856B (no) 1989-06-26
NO161856C NO161856C (no) 1989-10-04

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852519A NO161856C (no) 1984-06-22 1985-06-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,4-diamino-1,2,5-tiadiazol-derivater.

Country Status (33)

Country Link
US (1) US4644006A (no)
JP (2) JPS6118775A (no)
KR (1) KR900004321B1 (no)
AR (1) AR240935A1 (no)
AT (1) AT390790B (no)
AU (2) AU580605B2 (no)
BE (1) BE902724A (no)
CA (2) CA1267412A (no)
CH (1) CH665210A5 (no)
CS (1) CS257276B2 (no)
DD (1) DD240889A5 (no)
DE (1) DE3522101A1 (no)
DK (1) DK282885A (no)
ES (2) ES8702902A1 (no)
FI (1) FI852405L (no)
FR (1) FR2566406B1 (no)
GB (2) GB2161157B (no)
GR (1) GR851514B (no)
HU (1) HU193992B (no)
IE (2) IE58261B1 (no)
IL (1) IL75567A0 (no)
IT (1) IT1190372B (no)
LU (1) LU85969A1 (no)
NL (1) NL8501766A (no)
NO (1) NO161856C (no)
NZ (1) NZ212403A (no)
OA (1) OA08039A (no)
PT (1) PT80684B (no)
SE (1) SE464305B (no)
SU (1) SU1537136A3 (no)
YU (2) YU45725B (no)
ZA (1) ZA854710B (no)
ZW (1) ZW10385A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
ZW7683A1 (en) * 1982-03-29 1984-01-04 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2 receptor antagonist activity
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
AU2977589A (en) 1989-06-01
CA1267412A (en) 1990-04-03
OA08039A (fr) 1987-01-31
IT8521217A0 (it) 1985-06-20
SE8503110D0 (sv) 1985-06-20
GB8716149D0 (en) 1987-08-12
CS424785A2 (en) 1987-09-17
GR851514B (no) 1985-11-25
IL75567A0 (en) 1985-10-31
DK282885D0 (da) 1985-06-21
SU1537136A3 (ru) 1990-01-15
YU105185A (en) 1987-12-31
HUT42087A (en) 1987-06-29
AT390790B (de) 1990-06-25
YU102587A (en) 1988-02-29
SE464305B (sv) 1991-04-08
IE58261B1 (en) 1993-08-25
LU85969A1 (fr) 1986-01-24
GB2192884A (en) 1988-01-27
CH665210A5 (de) 1988-04-29
FR2566406B1 (fr) 1988-01-29
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
AU4392085A (en) 1986-01-02
YU45822B (sh) 1992-07-20
IE851557L (en) 1985-12-22
JPS6118775A (ja) 1986-01-27
FI852405A0 (fi) 1985-06-17
ES544409A0 (es) 1987-01-16
FI852405L (fi) 1985-12-23
ES8702902A1 (es) 1987-01-16
KR860000275A (ko) 1986-01-27
CS257276B2 (en) 1988-04-15
GB2161157A (en) 1986-01-08
BE902724A (fr) 1985-12-23
GB2192884B (en) 1988-08-10
US4644006A (en) 1987-02-17
JPS61186369A (ja) 1986-08-20
ZW10385A1 (en) 1986-02-05
AR240935A2 (es) 1991-03-27
KR900004321B1 (ko) 1990-06-22
NZ212403A (en) 1989-04-26
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
IT1190372B (it) 1988-02-16
ATA185885A (de) 1989-12-15
ZA854710B (en) 1986-02-26
AU580605B2 (en) 1989-01-19
DE3522101A1 (de) 1986-01-02
SE8503110L (sv) 1985-12-23
AR240935A1 (es) 1991-03-27
GB8515749D0 (en) 1985-07-24
YU45725B (sh) 1992-07-20
FR2566406A1 (fr) 1985-12-27
IE57937B1 (en) 1993-05-19
NO161856B (no) 1989-06-26
PT80684A (en) 1985-07-01
HU193992B (en) 1987-12-28
ES551506A0 (es) 1987-01-16
DK282885A (da) 1985-12-23
DD240889A5 (de) 1986-11-19
GB2161157B (en) 1988-08-10
PT80684B (en) 1987-05-08
ES8702881A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
TR22585A (tr) Bazi 2-(2'-alkilbenzoil)-1,3-sikloheksandion'lar
DE3574665D1 (de) Glutamatrezeptorshemmstoff.
DE3577675D1 (de) Rotationseinstellvorrichtung.
FI854973A0 (fi) Teofyllinprodukt med foerdroejd verkan.
FI842139A0 (fi) Avskjutningsanordning foer gevaer.
FI854800A0 (fi) Salter innehaollande 5'-metyltio -5'-deoxiadenocin med laong alkylkedja innehaollande sulfonsyror.
NO852519L (no) Substituerte 3,4-diamino-1,2,5-tiadiazoler med hestamin h2-reseptor antagonistisk virkning
NO831100L (no) Substituerte 3,4-diamino-1,2,5-tiadiazoler med histamin h2-reseptorantagonistvirkning
FI850783L (fi) Gasutvecklingsanordning med flere i en tryckgasbehaollare insatta gasflaskor.
FI851292A0 (fi) Vattentaet stickkontakt med lock.
FI844410L (fi) Slaepvagn med avlastning.
FI924018A (fi) 1,4-dihydropyridiner med paf-antagonisk aktivitet
FI853376A0 (fi) Braend kalk med foerlaengd hydratiseringstid.
FI854387A0 (fi) Eldfast strypstaelle foer foerbraenningsanordning med stor effekt.
FI863035A0 (fi) En vaetsketaett sluten behaollare med lock.
ZA852646B (en) Substituted sulphonylureas
FI843643L (fi) 2,5-disubstituerade-4(3h)-pyrimidoner med histamin-h2-receptor antagonistaktivitet.
FI860480A (fi) Antacidpulver med stor taethet.
DE3572662D1 (de) 2,3-dihydrobenzo-4-oxa-thiine
KR860001078Y1 (en) Supporter for the head
FI843425A0 (fi) Med saog fungerande isbrytare.
ZA852560B (en) 3-(2,2-tetramethylene-propyl)-1,3,5-triazine-2,4-diones
RO89149A2 (ro) Baza de supozitoare
GB8422842D0 (en) 7-oxo-4-thia-1-azabicyclo/3,2,0/hept-2-ene derivatives
SE8404012D0 (sv) Diskhopase med hallare